• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMGN:US

115.4600 USD 0.0800 0.07%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Amgen Inc (AMGN)

Open: 115.6100 Day's Range: 115.0200 - 117.1900 Volume: 3,237,732
Previous Close: 115.5400 52wk Range: 94.1500 - 128.9600 1-Yr Rtn: +9.39%

Stock Chart for AMGN

No chart data available.
  • AMGN:US 115.4600
  • 1D
  • 1M
  • 1Y
115.5400
Interactive AMGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMGN

Current P/E Ratio (ttm) 15.7929
Estimated P/E(12/2014) 14.1599
Relative P/E vs. SPX 0.9183
Earnings Per Share (USD) (ttm) 7.3109
Est. EPS (USD) (12/2014) 8.1540
Est. PEG Ratio 1.7676
Market Cap (M USD) 87,344.02
Shares Outstanding (M) 756.49
30 Day Average Volume 4,014,187
Price/Book (mrq) 3.9431
Price/Sale (ttm) 4.6541
Dividend Indicated Gross Yield 2.11%
Cash Dividend (USD) 0.6100
Dividend Ex-Date 05/13/2014
5 Year Dividend Growth -
Next Earnings Announcement 04/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMGN

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEOAnthony C Hooper "Tony"Exec VP:Global Commercial Ops
Madhavan BalachandranExec VP:OperationsSean E HarperExec VP:Research & Dev
More Company Profile & Key Executives for AMGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil